Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the impact of the 1 April reduction-in-force on the US Food and Drug Administration, which targeted about 3,500 employees (:30). They also consider whether and how service levels will change (13:28), and new Commissioner Martin Makary’s first address to the drastically smaller staff the day after the RIF was announced (29:22).
More On These Topics From The Pink Sheet
- Updated: US Likely To Lose Its First Approver Advantage After FDA Layoffs
- Are Bigger Ad Policy Changes Coming After US FDA’s Drug Promotion Office Hit Hard By Layoffs?
- Dramatic HHS Layoffs A Response To ‘Existential Crisis,’ Kennedy Advisor Argues
- CDRH Staff Cuts Focus On Administrative Workers, Spare Reviewers
- Makary Pledges To Uphold Gold Standard Science, But First Address Confuses Some US FDA Staff
- US FDA Restructuring May Be Next After Drugs Center Loses More Than 1,000 People
This and other podcasts are available on the Pink Sheet podcast page, as well as the Citeline channel on Apple Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
